Related Experiment Video
Updated: Jan 31, 2026

Studying Triple Negative Breast Cancer Using Orthotopic Breast Cancer Model
Published on: March 20, 2020
Prevalence and characterization of ATM germline mutations in Chinese BRCA1/2-negative breast cancer patients
Ziguo Yang1, Tao Ouyang1, Jinfeng Li1
1Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education/Beijing), Breast Center, Peking University Cancer Hospital & Institute, 100142, Beijing, People's Republic of China.
Purpose:
The ataxia telangiectasia-mutated (ATM) gene is a moderate susceptibility gene for breast cancer. However, little is known about the breast cancer phenotypes associated with ATM mutation. We therefore investigated the spectrum and clinical characteristics of ATM germline mutations in Chinese breast cancer patients.
Methods:
A multi-gene panel was performed to screen for ATM germline mutations in 7657 BRCA1/2-negative breast cancer patients. All deleterious mutations were validated by independent polymerase chain reaction (PCR)-Sanger sequencing.
Results:
A total of 31 pathogenic mutations in the ATM gene across 30 carriers were identified, and the ATM mutation rate was 0.4% (30/7,657) in this cohort. The majority of the mutations (90.3%, 28/31) were nonsense or frameshift mutations. Of the total ATM mutations, 61.3% (19/31) were novel mutations and 13 recurrent mutations were found. ATM mutations carriers were significantly more likely to have a family history of breast and/or ovarian cancer (26.7% in carriers vs. 8.6% in non-carriers, p < 0.001), as well as a family history of any cancer (60.0% in carriers vs. 31.5% in non-carriers, p = 0.001). In addition, ATM mutations carriers were significantly more likely to have oestrogen receptor (ER)-positive (p = 0.011), progesterone receptor (PR)-positive (p = 0.040), and lymph node-positive breast cancer (p = 0.034).
Conclusions:
The prevalence of the ATM mutation is approximately 0.4% in Chinese BRCA1/2-negative breast cancer. ATM mutation carriers are significantly more likely to have a family history of cancer and to develop ER- and/or PR-positive breast cancer or lymph node-positive breast cancer.
Insights
The ataxia telangiectasia-mutated (ATM) gene is linked to breast cancer risk. ATM mutation carriers often have a family cancer history and are more prone to developing ER/PR-positive or lymph node-positive breast cancer.
Area of Science:
- Genetics
- Oncology
- Molecular Biology
Background:
- The ataxia telangiectasia-mutated (ATM) gene is recognized as a moderate susceptibility gene for breast cancer.
- Limited information exists regarding the specific breast cancer phenotypes associated with ATM gene mutations.
Purpose of the Study:
- To investigate the spectrum and clinical characteristics of ATM germline mutations in Chinese breast cancer patients.
- To determine the prevalence and associated clinical features of ATM mutations in a BRCA1/2-negative cohort.
Main Methods:
- A multi-gene panel was utilized to screen 7657 BRCA1/2-negative breast cancer patients for ATM germline mutations.
- Deleterious mutations were confirmed using independent polymerase chain reaction (PCR)-Sanger sequencing.
Main Results:
- Thirty ATM mutation carriers were identified, yielding an ATM mutation rate of 0.4% (30/7,657).
- The majority of mutations were nonsense or frameshift (90.3%); 61.3% were novel.
- ATM mutation carriers showed a higher likelihood of family cancer history and developed ER-positive, PR-positive, and lymph node-positive breast cancer.
Conclusions:
- ATM mutations occur in approximately 0.4% of Chinese BRCA1/2-negative breast cancer patients.
- ATM mutation carriers are predisposed to a family history of cancer and specific breast cancer subtypes (ER/PR-positive, lymph node-positive).
Related Concept Videos
Prevalence and Incidence
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Mutations
Mutations
Chromosomal Alterations Are Large-Scale Mutations
While point mutations are changes in a single nucleotide in...
Cancers Originate from Somatic Mutations in a Single Cell
Viral Mutations
Mutation, Gene Flow, and Genetic Drift

